Successful Project Completion- RegenMatrix: Collagen-mimetic Bioactive
Hydrogels for Bone Regeneration
By Yash Mokashi, CMI Fellow
.png)
CMI would like to congratulate
the investigators of the project RegenMatrix for the successful completion of
their project with the aid of CMI funding. The investigators are Dr. Shilpa
Sant, Mr. Akhil Patel, Dr. Yadong Wang, Dr. Sachin Shankar Velankar and Dr. Charles
S. Sfeir.
CMI aims at facilitating the
translation of innovative biomedical technologies into marketable products and
services. Project RegenMatrix is an excellent example that meets all the CMI
success criteria.
Bone loss is a serious condition
without any effective treatment for inducing bone regeneration. Although bone
has natural healing capacity, trauma due to sports or other accidents cause
injuries beyond natural healing capacity. Bone loss also occurs due to tumors
and other bone degenerative diseases. In general, such problems are recorded
during emergency response or during consultations with physicians. In stark
contrast with current clinical management of bone loss, the investigators focus
on a regenerative strategy rather than a damage control strategy. The
RegenMatrix utilizes natural and biodegradable materials instead of synthetic
materials to regenerate functional bone tissue.
Using CMI funding of $20,000, the
investigators provided proof of concept and accomplished all initially set
milestones. A patent application was filed in 2016 and has been published in
2017. The work was presented at McGowan Institute Retreat 2017 and it was
awarded 2nd prize
in the ‘Medical Devices’ category. The team is currently seeking additional
funding to continue the project.
4/18/2017